                         SEQUENCE LISTING

<110>  Charit - Universittsmedizin Berlin
 
<120>  Mittel zur lokalen Behandlung von Zervixdysplasien

<130>  XI 197/11

<150>  DE 10 2010 016 475.5
<151>  2010-04-16

<160>  2     

<170>  PatentIn version 3.3

<210>  1
<211>  1248
<212>  DNA
<213>  artificial, from Human papilloma virus (HPV)

<400>  1
atggactcta cgcttcggtt gtgcgtacaa agcacacacg tagacattcg tactttggtc     60

gaccaattaa atgacagctc agaggaggag gatgaaatag atggtccagc tggacaagca    120

gaaccggaca gagcccatta caatattgta acctttgggc ccatgcatgg agatacacct    180

acattgcatg aatatatgtt agatttgcaa ccagagacaa ctgatcaatt gaagtgtgaa    240

gctagaattg agctagtagt agaaagctca gcagacgacc ttcgagcatt cagatctcaa    300

ttaagcgact cagaggaaga aaacgatgaa atagatggag ttaatcatca acatttacca    360

gcccgacgag ccgaaccaca acgtcacaca atgttggcta gcatgcatgg acctaaggca    420

acattgcaag acattgtatt gcatttagag cctcaaaatg aaattccggt tgacggtacc    480

aagcaaagac atctggacaa aaagcaaaga ttccataata taaggggtcg gtggaccggt    540

cgatccggat taaagtttta ttctaaaatt agtgagtata gacattattg ttatagtttg    600

tatggaacaa cattagaaca gcaatacaac aaaccgttgt gtgatttgtt aattaggcct    660

aggaagcaac agttactgcg acgtgaggta tatgactttg cttttcggga tttatgcata    720

gtatatagag atgggaatcc atatgctgta ccgcggccac aggagcgacc cagaaagtta    780

ccacagttat gcacagagct gcaaacaact atacatgata taatattaga atcgcgaaat    840

gaaaaacgac gattccacaa aatagctggg cactatagag gccagctcga gatagatttt    900

tattctagaa ttagagaatt aagacattat tcagactctg tgtatggaga cacattagaa    960

aaactaacta acactgggtt atacaattta ttaataagga ctagtaagac agtattggaa   1020

cttacagagg tatttgaatt tgcattcaaa gatttatttg tggtgtatag agacagtata   1080

ccgcatgctg cacacgtgcc aacacggcga ccctacaagc tacctgatct gtgcacggaa   1140

ctgaacactt cactgcaaga catagaaata acccttaagc tgatcccacg tcactattgt   1200

atactctata ttatactcta tgttatactc tgtaatccta ctcaataa                1248


<210>  2
<211>  415
<212>  PRT
<213>  artificial, from Human papilloma virus (HPV)

<400>  2

Met Asp Ser Thr Leu Arg Leu Cys Val Gln Ser Thr His Val Asp Ile 
1               5                   10                  15      


Arg Thr Leu Val Asp Gln Leu Asn Asp Ser Ser Glu Glu Glu Asp Glu 
            20                  25                  30          


Ile Asp Gly Pro Ala Gly Gln Ala Glu Pro Asp Arg Ala His Tyr Asn 
        35                  40                  45              


Ile Val Thr Phe Gly Pro Met His Gly Asp Thr Pro Thr Leu His Glu 
    50                  55                  60                  


Tyr Met Leu Asp Leu Gln Pro Glu Thr Thr Asp Gln Leu Lys Cys Glu 
65                  70                  75                  80  


Ala Arg Ile Glu Leu Val Val Glu Ser Ser Ala Asp Asp Leu Arg Ala 
                85                  90                  95      


Phe Arg Phe Gln Leu Ser Asp Ser Glu Glu Glu Asn Asp Glu Ile Asp 
            100                 105                 110         


Gly Val Asn His Gln His Leu Pro Ala Arg Arg Ala Glu Pro Gln Arg 
        115                 120                 125             


His Thr Met Leu Ala Ser Met His Gly Pro Lys Ala Thr Leu Gln Asp 
    130                 135                 140                 


Ile Val Leu His Leu Glu Pro Gln Asn Glu Ile Pro Val Asp Gly Thr 
145                 150                 155                 160 


Lys Gln Arg His Leu Asp Lys Lys Gln Arg Phe His Asn Ile Arg Gly 
                165                 170                 175     


Arg Trp Thr Gly Arg Ser Gly Leu Lys Phe Tyr Ser Lys Ile Ser Glu 
            180                 185                 190         


Tyr Arg His Tyr Cys Tyr Ser Leu Tyr Gly Thr Thr Leu Glu Gln Gln 
        195                 200                 205             


Tyr Asn Lys Pro Leu Cys Asp Leu Leu Ile Arg Pro Arg Lys Gln Gln 
    210                 215                 220                 


Leu Leu Arg Arg Glu Val Tyr Asp Phe Ala Phe Arg Asp Leu Cys Ile 
225                 230                 235                 240 


Val Tyr Arg Asp Gly Asn Pro Tyr Ala Val Pro Arg Pro Gln Glu Arg 
                245                 250                 255     


Pro Arg Lys Leu Pro Gln Leu Cys Thr Glu Leu Gln Thr Thr Ile His 
            260                 265                 270         


Asp Ile Ile Leu Glu Ser Arg Asn Glu Lys Arg Arg Phe His Lys Ile 
        275                 280                 285             


Ala Gly His Tyr Arg Gly Gln Leu Glu Ile Asp Phe Tyr Ser Arg Ile 
    290                 295                 300                 


Arg Glu Leu Arg His Tyr Ser Asp Ser Val Tyr Gly Asp Thr Leu Glu 
305                 310                 315                 320 


Lys Leu Thr Asn Thr Gly Leu Tyr Asn Leu Leu Ile Arg Thr Ser Lys 
                325                 330                 335     


Thr Val Leu Glu Leu Thr Glu Val Phe Glu Phe Ala Phe Lys Asp Leu 
            340                 345                 350         


Phe Val Val Tyr Arg Asp Ser Ile Pro His Ala Ala His Val Pro Thr 
        355                 360                 365             


Arg Arg Pro Tyr Lys Leu Pro Asp Leu Cys Thr Glu Leu Asn Thr Ser 
    370                 375                 380                 


Leu Gln Asp Ile Glu Ile Thr Leu Lys Leu Ile Pro Arg His Tyr Cys 
385                 390                 395                 400 


Ile Leu Tyr Ile Ile Leu Tyr Val Ile Leu Cys Asn Pro Thr Gln 
                405                 410                 415 


